3.0
23 Nov 2023
Former employee, more than 3 years
Cambridge, England
Recommend
CEO approval
Business outlook
Pros
Enormous growth potential especially in the oncology department
Cons
Unable to deal with the growth, lacking infrastructure, very competitive enviornment